Guru Ownership Trend
Guru Analysis for Protagonist Therapeutics, Inc. (PTGX)
Protagonist Therapeutics, Inc. (PTGX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $41.61 M.
Top institutional holders include Stanley Druckenmiller and George Soros.
Institutional sentiment is currently Bearish. This is evidenced by a $56.43 M net outflow during the quarter.
Recent activity highlights George Soros who opened a new position. Conversely, Jefferies Group reduced exposure by 99.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Protagonist Therapeutics, Inc. (PTGX)
Major holders include Stanley Druckenmiller ($13.95 M), George Soros ($8.73 M), Ken Fisher ($5.69 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 403,837 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $56.43 M, with 4 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited PTGX. The total reported sell value was $72.24 M.
Yes, 4 managers opened new positions in PTGX, and 0 increased their existing holdings. The total reported buy value was $15.81 M.
